Neutropenia management with palbociclib in Japanese patients with advanced breast cancer (vol 26, pg 637, 2019)

被引：0
|
作者：
Masuda, Norikazu [1 ]
Mukai, Hirofumi [2 ]
Inoue, Kenichi [3 ]
Rai, Yoshiaki [4 ]
Ohno, Shinji [5 ]
Mori, Yuko [6 ]
Hashigaki, Satoshi [6 ]
Muramatsu, Yasuaki [6 ]
Umeyama, Yoshiko [6 ]
Iwata, Hiroji [7 ]
Toi, Masakazu [8 ]
机构：
[1] Osaka Natl Hosp, Natl Hosp Org, Dept Surg, Breast Oncol,Chuou Ku, 2-1-14 Hoenzaka, Osaka 5400006, Japan
[2] Natl Canc Ctr Hosp East, Dept Breast & Med Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan
[3] Saitama Canc Ctr, Div Breast Oncol, 780 Komuro Inamachi, Saitama 3620806, Japan
[4] Sagara Hosp, 3-28 Tenokuchi Cho, Kagoshima 8920845, Japan
[5] Canc Inst Hosp, JFCR, Breast Oncol Ctr, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan
[6] Pfizer Japan Inc, Tokyo, Japan
[7] Aichi Canc Ctr Hosp, Dept Breast Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan
[8] Kyoto Univ, Grad Sch Med, Sakyo Ku, 54 Kawaracho, Kyoto 6068507, Japan
来源：
BREAST CANCER | 2019年 / 26卷 / 05期
关键词：
Advanced breast cancer; Cyclin-dependent kinase; Japanese patients; Neutropenia; Palbociclib;
D O I：
10.1007/s12282-019-00984-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The correct name of the last author should be "Masakazu Toi", and not ''Masakuzu Toi" as given in the original publication of the article.
引用
收藏
页码：651 / 651
页数：1
相关论文
共 50 条
  • [1] Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer
    Norikazu Masuda
    Hirofumi Mukai
    Kenichi Inoue
    Yoshiaki Rai
    Shinji Ohno
    Yuko Mori
    Satoshi Hashigaki
    Yasuaki Muramatsu
    Yoshiko Umeyama
    Hiroji Iwata
    Masakazu Toi
    [J]. Breast Cancer, 2019, 26 : 651 - 651
  • [2] Considering adequate amount of palbociclib due to neutropenia in 28 Japanese patients with advanced breast cancer - real world data of single institution
    Hirokawa, E.
    Iwasa, T.
    Sakai, H.
    Watanabe, S.
    Yonesaka, K.
    Komoike, Y.
    Nakagawa, K.
    [J]. BREAST, 2019, 44 : S58 - S59
  • [3] Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer
    Lynce, Filipa
    Blackburn, Matthew J.
    Zhuo, Rebecca
    Gallagher, Christopher
    Hahn, Olwen M.
    Abu-Khalaf, Maysa
    Mohebtash, Mahsa
    Wu, Tianmin
    Pohlmann, Paula R.
    Dilawari, Asma
    Tiwari, Shruti R.
    Chitalia, Ami
    Warren, Robert
    Tan, Ming
    Shajahan-Haq, Ayesha N.
    Isaacs, Claudine
    [J]. CANCER, 2021, 127 (19) : 3622 - 3630
  • [4] Real-World Predictors of Severe Neutropenia Associated with Palbociclib and Endocrine Therapy for Metastatic Breast Cancer in Japanese Patients
    Takada, Shinya
    Maeda, Hideki
    Umehara, Kengo
    Kuwahara, Sayuri
    Yamamoto, Mitsugu
    Tomioka, Nobumoto
    Watanabe, Kenichi
    Mino, Kozo
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2023, 46 (08) : 1105 - 1111
  • [5] Tolerability of palbociclib in younger and older patients with advanced breast cancer
    Dennison, Taylor
    Heiling, Hillary
    Deal, Allison
    Brunk, Kelly
    Kemper, Ryan
    Crona, Daniel J.
    Faso, Aimee
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (01) : 96 - 104
  • [6] Association between severe neutropenia and progression-free survival in patients with advanced or recurrent breast cancer treated with palbociclib
    Kimura, M.
    Usami, E.
    Yoshimura, T.
    [J]. PHARMAZIE, 2020, 75 (12): : 662 - 665
  • [7] Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases
    Turner, N. C.
    Finn, R. S.
    Martin, M.
    Im, S. -A
    DeMichele, A.
    Ettl, J.
    Dieras, V.
    Moulder, S.
    Lipatov, O.
    Colleoni, M.
    Cristofanilli, M.
    Lu, D. R.
    Mori, A.
    Giorgetti, C.
    Iyer, S.
    Bartlett, C. Huang
    Gelmon, K. A.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (03) : 669 - 680
  • [8] Outcomes and Cost of Outpatient or Inpatient Management of Patients With Febrile Neutropenia (vol 26, pg 606, 2008)
    Elting
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (24) : 2187 - 2187
  • [9] Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection (vol 26, pg 154, 2019)
    Talima, Soha
    Kassem, Hebatallah
    Kassem, Neemat
    [J]. BREAST CANCER, 2019, 26 (02) : 164 - 164
  • [10] Risk factors associated with palbociclib-induced neutropenia in patients with metastatic breast cancer
    Lavery, Lesli
    DiSogra, Kristyn
    Lea, Julia
    Trufan, Sally J.
    Symanowski, James T.
    Roberts, Ashley
    Moore, Donald C.
    Heeke, Arielle
    Pal, Sridhar
    [J]. SUPPORTIVE CARE IN CANCER, 2022, 30 (12) : 9803 - 9809
12345